No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
XGN250117C2500
- 1.20
- +0.56+87.50%
15min DelayClose Jan 3 16:00 ET
1.20High1.20Low
1.20Open0.64Pre Close1 Volume6 Open Interest2.50Strike Price120.00Turnover1149.26%IV3.35%PremiumJan 17, 2025Expiry Date1.08Intrinsic Value100Multiplier13DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type0.8939Delta0.0237Gamma1.30Leverage Ratio-0.0573Theta0.0002Rho1.16Eff Leverage0.0012Vega
Intraday
- 5D
- Daily
News
Exagen Is Maintained at Buy by Canaccord Genuity
Exagen Price Target Raised to $7.00/Share From $5.00 by Canaccord Genuity
Exagen Analyst Ratings
CCORF Maintains Exagen(XGN.US) With Buy Rating, Raises Target Price to $7
Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 27% Jump Looks Justified
Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone